Science Explorer Back to mapMap
Discussion
Researcher · University of Medicine Tirana · Albania

Iris Hoxha

Iris Hoxha publishes mostly in Economics and Econometrics, Applied Microbiology and Biotechnology and Geriatrics and Gerontology, on topics such as Antibiotic Use and Resistance, Pharmaceutical Economics and Policy and Health Systems, Economic Evaluations, Quality of Life.

OpenAlex
World rank
#259,362
of 7,710,434 ranked researchers
Rank in Albania
#3
of 1,070
Works
34
Citations
2.9k
Citations per work
86.2
h-index
20
i10-index 24Top 11% in Economics and Econometrics
Iris Hoxha

What does Iris Hoxha research?

Iris Hoxha's work is mostly in Economics, Econometrics and Finance (30%), Immunology and Microbiology (23%), Medicine (21%).

Social Sciences: 10 works · 29.8% of their workEconomics, Econometrics and Finance: 10 works · 29.8% of their workEconomics and Econometrics: 10 works · 29.8% of their workEverything else: 9 works · 25.6% of their workLife Sciences: 8 works · 23.4% of their workImmunology and Microbiology: 8 works · 23.4% of their workApplied Microbiology and Biotechnology: 6 works · 19.1% of their workImmunology: 1 works · 4.3% of their workHealth Sciences: 7 works · 21.2% of their workMedicine: 7 works · 21.2% of their workGeriatrics and Gerontology: 3 works · 8.5% of their workEpidemiology: 3 works · 7.4% of their workPediatrics, Perinatology and Child Health: 2 works · 5.3% of their workTHEIR WORKIris Hoxha34works
Life Sciences23%Health Sciences21%Social Sciences30%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Economics, Econometrics and Finance1029.8%
  2. Everything else925.6%
    1. Immunology and Microbiology823.4%
    1. Medicine721.2%
  1. 1Economics and Econometrics30% of their works
  2. 2Applied Microbiology and Biotechnology19% of their works
  3. 3Geriatrics and Gerontology8% of their works
  4. 4Epidemiology7% of their works
  5. 5Pediatrics, Perinatology and Child Health5% of their works
  6. 6Immunology4% of their works

Research topics

Which keywords describe Iris Hoxha's research?

The keywords of their largest research topics: Epidemiology, Antibiotic Resistance, Antimicrobial Stewardship, Global Health, Drug Development Costs, Generic Drugs, Cost-effectiveness Analysis and Quality of Life.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.

All 18 words, with their numbers
  1. Epidemiology232 topics
  2. Antibiotic Resistance212 topics
  3. Antimicrobial Stewardship181 topic
  4. Global Health181 topic
  5. Drug Development Costs141 topic
  6. Generic Drugs141 topic
  7. Cost-effectiveness Analysis91 topic
  8. Quality of Life91 topic
  9. Inappropriate Medication Use81 topic
  10. Polypharmacy81 topic
  11. Community-Acquired Pneumonia51 topic
  12. Pneumococcal Conjugate Vaccine51 topic
  13. Cost of Care41 topic
  14. Financial Toxicity41 topic
  15. Off-Label Drug Use41 topic
  16. Pediatric Pharmacokinetics41 topic
  17. ESKAPE Pathogens31 topic
  18. Multidrug-Resistant Bacteria31 topic

Where does Iris Hoxha work?

Iris Hoxha's main affiliation in the publication record is University of Medicine Tirana, Albania.

How many publications and citations does Iris Hoxha have?

OpenAlex counts 34 works and 2,931 citations for Iris Hoxha, an h-index of 20, ranking #259,362 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Iris Hoxha. Posts are plain text and can be reported.